Charles River Laboratories (CRL) Tops Q1 EPS by 12c, Raises FY EPS Guidance

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 7/7/2026

6. SPGI
7. RIVN
8. LMT
9. BFH
10. AGIO

Get Alerts CRL Hot Sheet

Price: $231.43 --0%

Revenue Growth %: -5.1%

Financial Fact:
Discontinued operations (in dollars per share): 0.01

Today's EPS Names:
EPAC, SAR, KRUS, More

Join SI Premium – FREE

Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $1.38, $0.12 better than the analyst estimate of $1.26. Revenue for the quarter came in at $494.4 million versus the consensus estimate of $480.75 million.

GUIDANCE:

Charles River Laboratories sees FY2018 EPS of $5.77-$5.92, versus the consensus of $5.76.


2018 GUIDANCE INCLUDING MPI RESEARCH(from continuing operations)	REVISED	PRIOR
Revenue growth, reported	18% - 20%	16% - 18%
Less: Contribution from acquisitions (1)	(9.5% - 10.5%)	(9.5% - 10.5%)
Less: Favorable impact of foreign exchange	(~3%)	(~1%)
Revenue growth, organic (2)	5.7% - 6.7%	5.7% - 6.7%
GAAP EPS estimate	$4.22-$4.37	---
Amortization of intangible assets (3)	$1.00-$1.10	---
Charges related to global efficiency initiatives (4)	$0.09	---
Acquisition-related adjustments (5)	$0.41	---
Non-GAAP EPS estimate	$5.77 - $5.92	$5.67 - $5.82

For earnings history and earnings-related data on Charles River Laboratories (CRL) click here
.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

Create E-mail Alert Related Categories

Earnings, Guidance

Related Entities

Earnings

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!